Collins M S, Pappagianis D
Antimicrob Agents Chemother. 1977 Jun;11(6):1049-55. doi: 10.1128/AAC.11.6.1049.
The susceptibility of 12 strains of Coccidioides immitis to amphotericin B (amB) was studied in vitro and in vivo. The minimal inhibitory concentration (MIC) of the mycelial phase of these strains was 0.078 to 0.16 mug/ml after 3 days of incubation, but by 15 days all strains were inhibited by 2.5 mug/ml. Mice infected intraperitoneally with these strains were sucessfully treated with 0.5 mg of amB per kg per day. These strains included several studied by others and which reportedly varied widely in susceptibility (MIC from 0.24 to 24.01 mug/ml) to amB. Four of these strains representing this putative broad range of susceptibility were used to infect mice intranasally. Regardless of infecting strain, mice were sucessfully treated with 0.38, 0.75, and 1.5 mg/kg, but 0.19 mg/kg was only partially effective. Thus, in vivo as well as in vitro there was a uniform response of C. immitis strains to amB.
对12株粗球孢子菌进行了两性霉素B(amB)的体外和体内敏感性研究。这些菌株菌丝体阶段在培养3天后的最低抑菌浓度(MIC)为0.078至0.16微克/毫升,但到15天时,所有菌株均被2.5微克/毫升抑制。腹腔感染这些菌株的小鼠每天按每千克0.5毫克的剂量给予amB治疗成功。这些菌株包括其他研究过的一些菌株,据报道它们对amB的敏感性差异很大(MIC为0.24至24.01微克/毫升)。选取其中代表这种假定广泛敏感性范围的4株菌株经鼻感染小鼠。无论感染菌株如何,小鼠用0.38、0.75和1.5毫克/千克剂量治疗均成功,但0.19毫克/千克仅部分有效。因此,粗球孢子菌菌株在体内和体外对amB均有一致反应。